Entering text into the input field will update the search result below

IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q2 2021 Results - Earnings Call Transcript

Aug. 04, 2021 10:17 AM ETIVERIC bio, Inc. (ISEE)
SA Transcripts profile picture
SA Transcripts

IVERIC bio, Inc. (NASDAQ:ISEE) Q2 2021 Results Earnings Conference Call August 4, 2021 8:00 AM ET

Company Participants

Kathy Galante - Senior Vice President, Investor Relations

Glenn Sblendorio - Chief Executive Officer

Keith Westby - Chief Operating Officer

Pravin Dugel - President

David Carroll - Chief Financial Officer

Christopher Simms - Chief Commercial Officer

Conference Call Participants

Stacy Ku - Cowen and Company

Tiago Fauth - Credit Suisse

David Nierengarten - Wedbush Securities


Good morning and welcome to the IVERIC bio Second Quarter 2021 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions]. After today's presentation, there will be an opportunity to ask questions. [Operator Instructions]. Please note, today's event is being recorded.

I would now like to turn the conference over to Kathy Galante, Senior Vice President, Investor Relations. Ms. Galante, please go ahead.

Kathy Galante

Thank you, Keith. Good morning and welcome to IVERIC bio's conference call. Representing IVERIC bio today are Mr. Glenn Sblendorio, Chief Executive Officer; Dr. Pravin Dugel, President; Mr. Keith Westby, Chief Operating Officer; Mr. Dave Carroll, Chief Financial Officer; Dr. Dhaval Desai, Chief Development Officer; Dr. Abraham Scaria, Chief Scientific Officer; and Mr. Chris Simms, Chief Commercial Officer.

I would like to remind you that today we will be making statements relating to IVERIC bio's future expectations regarding operational, financial and research and development matters. These statements constitute forward-looking statements for the purposes of the Safe Harbor provision under the Private Securities Litigation Reform Act of 1995. These statements cover many events and matters that are subject to various risks that could cause actual results to differ materially from those expressed in any forward-looking statement.

I refer you to our SEC filings and, in particular, to the risk factors included in our quarterly report on Form 10-Q filed on May 5, 2021, for

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.